The authors identified L1CAM as a crucial regulatory factor for modulating vasculogenic mimicry formation in glioma, which might be a potential target for ameliorating tumor resistance to antiangiogenic therapy in glioma patients. This evidence concerns the gene L1CAM and central nervous system cancer.